𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice

✍ Scribed by Sean Jabbar; Katerina Strati; Myeong Kyun Shin; Henry C. Pitot; Paul F. Lambert


Book ID
113948160
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
386 KB
Volume
407
Category
Article
ISSN
0042-6822

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Antibodies against oncoproteins E6 and E
✍ Klaus Zumbach; Markus Hoffmann; Tomas Kahn; Franz Bosch; Stefan Gottschlich; Tib πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 69 KB πŸ‘ 1 views

Human papillomaviruses (HPVs) have been recognized as an essential pathogenic factor in anogenital cancer. HPV DNA has also been found in a subgroup of head-and-neck squamous-cell carcinomas (HNSCCs), and a causative role of the virus in the development of these tumors has been suggested by the conc

Inhibition of apoptosis in human larynge
✍ Han Ching Liu; George G. Chen; Alexander C. Vlantis; Gary M. Tse; Anthony T.C. C πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 749 KB

## Abstract The carcinogenesis of human papillomaviruses type 16 (HPV‐16) is mainly due to its two oncoproteins, E6 and E7. Their carcinogenic features in term of their relationship with Bcl‐2 family are still unclear. We thus aimed to analyze the expression of Bcl‐2 family members, Bcl‐2, Bax, and

Risk factors and survival by HPV-16 E6 a
✍ Elaine M. Smith; Michael Pawlita; Linda M. Rubenstein; Thomas H. Haugen; Eva Ham πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 201 KB

## Abstract High‐risk human papillomavirus types (HPV‐HR) are associated with head and neck cancer (HNC) risk and better survival. Most patients with HPV‐HR DNA‐positive tumors develop anti‐HPV E6/E7 antibodies; however, it is unclear whether those who mount an immune response have similar risk fac